openPR Logo
Press release

Hormonal Contraceptives Market Size, Company Profiles And Key Figures Reviewed In Latest Research Report 2022-2030 | Novartis AG, Allergan plc., Apothecus Pharmaceutical Corporation, Pfizer, Inc., Bayer AG

02-07-2023 10:06 AM CET | Health & Medicine

Press release from: Growth Plus Reports

Newark, New Castle, USA: Hormonal Contraceptives Market by Hormone (Progestin Only and Combined Hormones), by Product (Hormonal Implants, Hormonal Intrauterine Devices, Oral Contraceptives and Skin Patches), by Age-Group (15-24 Years, 25-34 Years,35-44 Years and 45 Years & Above), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Gynecology/Fertility Clinics ) - Global Outlook & Forecast 2022-2030. Covid 19 Outbreak Impact research report added by Growth Plus Reports, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Hormonal Contraceptives market, and compares it with other markets., market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Hormonal Contraceptives market size forecast, market data & Graphs and Statistics, Tables, Bar &Pie Charts, and many more for business intelligence. Get a complete Report (Including Full TOC, 100+ Tables & Figures, and a Chart). - In-depth Analysis Pre & Post COVID-19 Market Outbreak Impact Analysis & Situation by Region.

Download Free Sample Copy of the 'Hormonal Contraceptives market' Report @ https://www.growthplusreports.com/inquiry/request-sample/hormonal-contraceptives-market/7790

Leading Competitors

The prominent players in the global Hormonal Contraceptives market are: Novartis AG, Allergan plc., Apothecus Pharmaceutical Corporation, Pfizer, Inc., Bayer AG, Merck & Co. Inc., Teva Pharmaceuticals Industries Ltd., Afaxys, Inc., Lupin Pharmaceuticals, Mylan N.V., CooperSurgical Inc., Johnson & Johnson Services, Inc./Janssen Pharmaceuticals Inc.

By Hormone: Progestin Only and Combined Hormones

By Product: Hormonal Implants, Hormonal Intrauterine Devices, Oral Contraceptives and Skin Patches

By Age-Group: 15-24 Years, 25-34 Years,35-44 Years and 45 Years & Above

By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Gynecology/Fertility Clinics

Geographical Breakdown: The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery path of Covid 19 for all regions, key developed countries and major emerging markets.

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Key questions answered: Study Explore COVID-19 Outbreak Impact Analysis Our team will be able to provide clear answers, identify key opportunities, new investments, and recommend high-quality strategy routes in the market. These answers will include a holistic analysis of the:

Existing market infrastructures
Market challenges and opportunities
Potential for growth in certain industries in the coming years
End-consumer target groups and their potential volumes of operation
Best regions and segments to target
Pros and cons of various promotion models
Touch points and an opportunity breakdown within the value chain
Market size and growth rate during forecast period.
Key factors driving the Market.
Key market trends cracking up the growth of the Market.
Challenges to market growth.
Key vendors of Market.
Detailed SWOT analysis.
Opportunities and threats faces by the existing vendors in Global Market.
Trending factors influencing the market in the geographical regions.
Strategic initiatives focusing the leading vendors.
PEST analysis of the market in the five major regions.

The Study Explore COVID 19 Outbreak Impact Analysis

What should be entry strategies, countermeasures to economic impact, and marketing channels?
What are market dynamics?
What are challenges and opportunities?
What is economic impact on market?
What is current market status? What's market competition in this industry, both company, and country wise? What's market analysis by taking applications and types in consideration?

Quick buy this reports now: https://www.growthplusreports.com/checkout-7790

Manan Sethi
Director, Market Insights
Email: sales@growthplusreports.com
Phone no: +44 808 238 7532
Web: https://www.growthplusreports.com/

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as ""Most Innovative Healthcare Market Research Company in 2020.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hormonal Contraceptives Market Size, Company Profiles And Key Figures Reviewed In Latest Research Report 2022-2030 | Novartis AG, Allergan plc., Apothecus Pharmaceutical Corporation, Pfizer, Inc., Bayer AG here

News-ID: 2917627 • Views:

More Releases from Growth Plus Reports

Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation Therapies Redefining Treatment
Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation T …
Newark, New Castle, USA: The "Germ Cell Tumor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Germ Cell Tumor Market: https://www.growthplusreports.com/report/germ-cell-tumor-market/8949 This latest report researches the industry structure,
Atypical Hemolytic Uremic Syndrome Treatment Market - Revolutionizing AHUS Care: Next-Generation Therapies Leading the Way
Atypical Hemolytic Uremic Syndrome Treatment Market - Revolutionizing AHUS Care: …
Newark, New Castle, USA: The "Atypical Hemolytic Uremic Syndrome Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Atypical Hemolytic Uremic Syndrome Treatment Market: https://www.growthplusreports.com/report/atypical-hemolytic-uremic-syndrome-treatment-market/8948 This latest report
Adenine Phosphoribosyltransferase Deficiency Therapeutics Market - Lighting the Path to Relief: APRT Therapeutics Paving the Way
Adenine Phosphoribosyltransferase Deficiency Therapeutics Market - Lighting the …
Newark, New Castle, USA: The "Adenine Phosphoribosyltransferase Deficiency Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Adenine Phosphoribosyltransferase Deficiency Therapeutics Market: https://www.growthplusreports.com/report/adenine-phosphoribosyltransferase-deficiency-therapeutics-market/8946 This latest report researches the
Mycobacterium Bovis Treatment Market - Revolutionizing Mycobacterium Bovis Treatment: Breakthroughs in Combating the Infection
Mycobacterium Bovis Treatment Market - Revolutionizing Mycobacterium Bovis Treat …
Newark, New Castle, USA: The "Mycobacterium Bovis Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Mycobacterium Bovis Treatment Market: https://www.growthplusreports.com/report/mycobacterium-bovis-treatment-market/8945 This latest report researches the industry structure,

All 5 Releases


More Releases for Hormonal

United States Endometriosis Treatment Market Report 2025: Pain Medication, Hormo …
The Global Endometriosis Treatment market reached US$ 1.59 billion in 2024 and is expected to reach US$ 3.91 billion by 2033, growing at a CAGR of 10.62% during the forecast period 2025-2033. The Endometriosis Treatment Market encompasses the range of pharmaceutical drugs, hormonal therapies, surgical interventions, and diagnostic tools used to manage and treat endometriosis a chronic condition where tissue similar to the endometrium grows outside the uterus, causing pain, infertility,
Contraceptives Market Detailed in New Research Report with Emerging Hormonal and …
Contraceptives Market Insights Global contraceptive market was valued US$ 19.79 Bn in 2025 and is expected to reach US$ 47.14 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 13.20% from 2025 to 2032. Coherent Market Insights has released a detailed analysis of the Contraceptives Market (2025-2032), focusing on the evolving U.S. healthcare landscape. The report presents critical metrics such as market size, revenue forecasts, CAGR, adoption patterns, and key
Hormonal Contraceptives Market - Confidence, Convenience, and Control: Elevating …
Newark, New Castle, USA: The "Hormonal Contraceptives Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Hormonal Contraceptives Market: https://www.growthplusreports.com/report/hormonal-contraceptives-market/7790 This latest report researches the industry structure, sales, revenue,
Non-Hormonal Birth Control Market - Empowering Choice, Embracing Control: Non-Ho …
Newark, New Castle, USA - new report, titled Non-Hormonal Birth Control Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Non-Hormonal Birth Control market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Non-Hormonal Birth Control market. The report offers an overview of
Hormonal Contraceptives Market Size, Share | Hormonal Contraceptives Industry Fu …
Global Hormonal Contraceptives Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Hormonal Contraceptives Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,
High Awareness in Female Population Regarding Hormonal Disorders Drives the Pres …
Global Prescription Hormonal Drugs Market in Gynecology: Description Hormonal imbalance in women is caused due to abnormalities in the secretion of estrogen, progesterone and as well as androgens. A wide array of symptoms might be experienced by patients depending on the type of abnormality such as hot flushes, depression, vaginal dryness, excessive hair growth and abnormal vaginal bleeding. Environmental and genetic factors have an influence on women's fertility through their effect